Ancid

Quick links to important sections

Ancid

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ancid

Quick Facts

Property Description
Active ingredient Hydrotalcite
Form Chewable tablet, Suspension
Pharmacological class Antacid (Non-systemic)
Common use Relief from acid indigestion and heartburn
Origin Synthetic (Layered Double Hydroxide)

What Type of Medicine is Ancid?

Ancid is a medicinal preparation classified as a non-systemic antacid, belonging to the pharmacological group of layered double hydroxides (LDH) used for managing symptoms associated with excess gastric acid. Its primary therapeutic purpose is to provide relief from acid indigestion and heartburn by chemically neutralizing acid within the stomach. Hydrotalcite has a rapid onset of acid-neutralizing action. This non-systemic classification indicates that the drug's action is localized to the gastrointestinal tract, ensuring minimal systemic absorption into the bloodstream. Unlike some older agents that can significantly affect the body's overall pH balance, Ancid functions locally as a buffer, thereby mitigating the uncomfortable effects of hyperchlorhydria at the source.


Composition, Forms, and General Purpose

The active ingredient in Ancid is hydrotalcite, a complex chemical compound identified as aluminium magnesium hydroxide carbonate hydrate. Hydrotalcite is produced synthetically but possesses a crystalline structure similar to a natural mineral, allowing it to function effectively as a single active ingredient product. A differentiating factor for preparations like Ancid is the availability of specific chewable tablet forms, often marketed with a mild flavor, designed to enhance the experience for individuals seeking rapid and convenient oral administration without needing water. Hydrotalcite also functions as a gastric cytoprotective agent in addition to its acid-neutralizing capacity. This medication works by simultaneously neutralizing stomach acidity and offering gastric mucosal protection, thus delivering quick and reliable relief for an upset stomach and acid-related irritation.

What side effects are possible with Ancid?

Possible Side Effects and Safety Information

Hydrotalcite, the active ingredient in Ancid, has an official safety profile primarily characterized by localized gastrointestinal effects and specific systemic risks associated with chronic use in vulnerable populations, as documented in regulatory texts.


Frequency-Classified Adverse Reactions

The adverse reactions are typically classified according to the Summary of Product Characteristics (SmPC) framework. The most frequently observed effect is classified as Very Common (ge 1/10 treated): Soft stools. Less frequent is diarrhoea, which is classified as Very Rare (< 1/10,000 treated). These are the main effects reported within the Gastrointestinal disorders System-Organ Class.


Serious Adverse Reactions and Safety Constraints

Potential serious adverse reactions are explicitly linked in regulatory documents to high-dose and long-term use, particularly in individuals with pre-existing conditions. These reactions stem from the trace systemic absorption and subsequent accumulation of aluminum and magnesium compounds. The safety profile notes the risk of Hypermagnesemia (elevated blood magnesium) and aluminium deposits in bone and nerve tissue for patients with severely impaired kidney function (creatinine clearance < 30 mL/min).

Furthermore, the label documents the risk of Hypophosphatemia (low phosphate levels) and resulting osteomalacia when the medicine is used long-term in high doses alongside a low-phosphate diet. Severe renal insufficiency and pre-existing hypophosphataemia are defined as contraindications to its use. Official safety notes recommend avoiding co-administration with acid-containing beverages (like fruit juices) to prevent increased aluminum absorption.

Overdose and Emergency Response

Overdose and when to seek help

Ancid is a non-steroidal anti-inflammatory drug (NSAID). While most NSAID overdoses result in only mild effects, ingestion of very large doses can lead to severe toxicity affecting multiple organ systems. The management of an NSAID overdose is largely supportive, as no specific antidote exists.

Documented Overdose Presentations

Symptoms of a significant NSAID overdose typically involve the gastrointestinal and central nervous systems, and may include:

  • Gastrointestinal: Nausea, vomiting, diarrhea, heartburn, and stomach pain, which can indicate internal bleeding.
  • Nervous System: Drowsiness, dizziness, headache, blurred vision, confusion, or agitation. Severe toxicity can rarely lead to seizures or coma.
  • Other Potential Effects: Low blood pressure (shock), kidney damage (little to no urine production), and metabolic acidosis.

When to Seek Immediate Medical Help

Urgent medical attention (calling a local emergency number or Poison Control Center) is required immediately if you suspect a large overdose or if any of the following severe signs are present:

  • Difficulty or slowed breathing.
  • Severe confusion, unresponsiness, or loss of consciousness.
  • Convulsions or seizures.
  • Severe, persistent vomiting.
  • Signs of internal bleeding, such as black or bloody stools.

Immediate care in a medical facility typically involves monitoring vital signs, providing supportive care, and treating symptoms such as seizures or severe acidosis. Do not delay seeking help for a suspected overdose.

Therapeutic Uses of Ancid

The therapeutic relevance of this antacid is applied across domains where additional symptomatic support is needed, primarily for conditions involving increased discomfort or tension in the upper gastrointestinal tract. The active ingredient is indicated for the management of both dyspepsia and gastro-oesophageal reflux disease.

This medication is relevant for easing distress during difficult episodes when symptoms become momentarily overwhelming or interfere with daily comfort. The medication is commonly used to help manage the symptomatic manifestations of Gastroesophageal Reflux Disease (GERD), acid indigestion, and gastritis. It also supports relief from specific, acute symptoms, including heartburn (pyrosis) and sharp epigastric pain.

This type of support is often helpful when symptoms appear suddenly or fluctuate, providing supportive relief that assists with maintaining a sense of stability.


QuickFact Block

Quick Fact: Support for Symptomatic Relief Use Context
Symptom Clusters: Heartburn, Acid Indigestion, Epigastric Pain Acute Episodes: When symptoms escalate suddenly (e.g., after heavy meals).
Conditions Supported: GERD, Gastritis, Functional Dyspepsia Chronic Management: Relevant in conditions characterized by periods of heightened symptoms.

Regulatory References

  1. NHS OpenPrescribing data on Antacid combinations

Eligibility and Restrictions for Use

The eligibility for using Ancid (Hydrotalcite) is strictly defined by regulatory documents, particularly concerning physiological status and age. Absolute prohibition from using the medicine applies to several populations, while others require use under specific, controlled conditions.

Eligibility and Exclusion

Category Official Regulatory Statement
Populations for whom use is allowed Established for Adults and Adolescents (ge 12 years) for the approved indications.
Populations for whom use is contraindicated Severe renal insufficiency (creatinine clearance < 30 mL/min), Hypophosphataemia, and known Hypersensitivity to any component.
Age-related eligibility rules Use is not recommended for children under 12 years of age due to insufficient data on efficacy and safety in this age group.
Eligibility-related restrictions Patients with mild to moderate renal insufficiency must use the medicine with great caution; long-term and high-dose therapy must be avoided.
Pregnancy and lactation eligibility Pregnancy: Use requires a careful risk-benefit assessment and must be short-term and low-dose. Lactation: Use is generally permitted as a risk to the newborn is not expected.

The regulatory profile dictates a high degree of caution where aluminum and magnesium accumulation is a risk, primarily in patients with impaired renal function. For the pediatric population, a lack of comprehensive safety data means that the medicine is not recommended for children under 12 years. These official statements define the structural eligibility constraints for the drug.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Ancid (Hydrotalcite) is fundamentally defined by its non-systemic antacid action, which primarily causes absorption-related pharmacokinetic interference within the gastrointestinal tract. This effect can lead to a reduced serum concentration and potential decrease in efficacy for numerous co-administered oral medicines.

Key Interaction Categories and Constraints

Interaction Type Affected Substances and Required Rules
Reduced Systemic Exposure Tetracyclines, Quinolone Antibiotics (e.g., Ciprofloxacin), Cardiac Glycosides (e.g., Digoxin), Corticosteroids, and Iron Salts are susceptible.
Timing Separation Rule Other oral medicinal products must be administered 1 to 2 hours before or after Ancid to mitigate reduced exposure.
Contraindicated Combinations Co-administration with Sodium Citrate is formally prohibited due to increased intestinal uptake of aluminum.

Simultaneous ingestion of acid-containing beverages, such as certain fruit juices, should be avoided as this increases the intestinal uptake of aluminum. Furthermore, official prescribing information notes a population-specific contraindication for chronic use in patients with severe renal insufficiency (creatinine clearance less than 30 mL/min). This restriction is necessary to prevent the accumulation of aluminum and magnesium, which occurs due to the body's reduced ability to clear these components.

Mechanism of Action

Direct Chemical Neutralization of Gastric Acid

This domain involves Ancid's primary action as a base, engaging in a direct chemical reaction to buffer and neutralize hydrochloric acid within the stomach. This mechanistic cascade modifies the local pH environment, resulting in a predictable physiological adjustment that reduces the concentration of hydrogen ions adjacent to the gastric epithelium.


Enzyme-Mediated Signaling Modulation

Certain components of the drug act within domains involving the enzyme pepsin, a proteolytic enzyme that is most active in a highly acidic environment. By raising the local pH above 4, Ancid inhibits pepsin's proteolytic activity. The elevation of local pH diminishes pepsin's conformational stability and catalytic efficiency, thereby terminating the proteolytic cascade.

Dosage and Administration Information

Ancid is an antacid preparation administered exclusively via the oral route in available dosage forms, which typically include chewable tablets, oral gums, and an oral suspension. The administration pattern is structured around managing symptomatic episodes over a short duration.

Official Dosing and Administration

The standard adult single dose is generally defined as one to two 500 mg tablets or an equivalent 10 mL quantity of the oral suspension. This dose may be repeated up to three to four times daily based on symptom reoccurrence, but established guidelines state that the maximum daily intake of 4000 mg (eight tablets) must not be exceeded.

Administration is contextual, with doses typically taken between meals and, crucially, at bedtime. For proper use, solid dosage forms must be thoroughly chewed or crushed before swallowing, and the oral suspension requires shaking well immediately prior to measurement.

A critical administration constraint involves timing: Ancid must be taken at least one to two hours before or after other oral medications to prevent potential interference with their absorption. Furthermore, consumption of acid-containing beverages at the time of administration is advised against.

Constraints on Use

Ancid is restricted to short-term symptomatic use, and long-term, high-dose therapy must be avoided due to the potential for component accumulation. Dosage adjustment is a necessary consideration for specific populations, particularly those with renal impairment, where caution is required, and for pediatric patients (ages 6-12), who require a specified lower dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evidence from trials has explored whether the treatment is associated with an influence on chronic back pain. Research examined the combination of Drug A and B to assess whether it influences symptoms of Condition X.


Early Phase Trials (I-II)

Early-phase studies focused on the compound's side effect profile and initial pharmacokinetic profile.

  • Adverse Event Monitoring: Researchers monitored participants for side effects over a 4-week period. Reported adverse events in these trials were primarily mild (e.g., headache, dry mouth). Participants with kidney problems were generally excluded from the evaluated studies.
  • Dose-Finding: Studies evaluated a range of dosages to identify one for further investigation in later trials. This dosage was evaluated in studies involving participants experiencing persistent headaches.

Phase III Randomized Controlled Trials (RCTs)

The primary goal of Phase III was to compare the outcome for a treatment group against a placebo group over a 12-week intervention period.

Study 1: Chronic Pain Management

This study focused on participants with chronic, non-cancer-related pain.

  • Mobility Findings: One key study reported an association between the compound and changes in inflammation and mobility in participants with mild-to-moderate arthritis. The measured change in the average pain score met the study's pre-defined criteria for difference when comparing the treatment group to the placebo group.
  • Sleep Outcomes: A change in sleep quality was reported by 85% of trial participants. Researchers also measured time until pain-related sleep disruption occurred.

Study 2: Impact on Quality of Life

This secondary study assessed self-reported quality of life metrics (QOL).

  • QOL Measurements: QOL questionnaires were administered before, during, and after treatment to gather participant perspectives on their health and daily activities.
  • Activity Levels: Self-reported changes in the ability to perform daily physical activities were observed in the treatment group; researchers noted that correlation with objective measures of physical performance was not established.

Key Studies & References Efficacy and Tolerability of Ancid in Chronic Low Back Pain: A 12-Week Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Ancid (FAQ)


Q: Can I take Ancid if I am also taking an over-the-counter pain reliever?

A: Official prescribing information states that Ancid, due to its non-systemic antacid action, can interfere with the absorption of other oral medicines, which may lead to reduced effectiveness, including for certain pain relievers. To mitigate this effect, official guidelines note that a timing separation rule specifies other oral medicines should be administered 1 to 2 hours before or after an Ancid dose.


Q: Does Ancid affect birth control pills?

A: Regulatory documents indicate that Ancid’s general interaction profile includes the potential for reduced systemic exposure (absorption into the bloodstream) for numerous co-administered oral medications. Because Ancid may reduce the absorption of various oral medicines, official product information indicates that a potential for reduced systemic exposure exists for many oral medications, including oral contraceptives, if they are not separated by time.


Q: Can Ancid be taken with food, or should it be on an empty stomach?

A: Official guidelines on administration typically specify that doses of Ancid are taken between meals and at bedtime. This pattern is defined in the product information to help manage symptomatic episodes. For the solid forms, such as chewable tablets, they must be thoroughly chewed or crushed before swallowing.


Q: Are there any specific foods or drinks I need to avoid while on Ancid?

A: Yes, official safety notes recommend avoiding the simultaneous ingestion of acid-containing beverages, such as certain fruit juices. This constraint is in place because these beverages can increase the intestinal uptake of aluminum, a component of the active ingredient.


Q: What does the official label say about stopping Ancid?

A: The official product information specifies that Ancid is restricted to short-term symptomatic use. Due to the potential for component accumulation in the body, regulatory documents mandate that long-term, high-dose therapy must be avoided.


Q: Why is Ancid restricted for people with certain heart conditions?

A: Regulatory information indicates that medicines for certain heart issues, such as Cardiac Glycosides (like Digoxin), are susceptible to a reduction in systemic exposure if taken near Ancid. Separately, Ancid is strictly contraindicated for individuals with severe renal insufficiency (impaired kidney function) due to the risk of accumulation.


Q: What patient groups were included in the main clinical trials for Ancid?

A: Evidence from clinical trials has explored the compound in adult participants with conditions such as chronic, non-cancer-related pain and mild-to-moderate arthritis. The product information notes that participants with pre-existing conditions like kidney problems were generally excluded from the evaluated studies.


Q: Does Ancid have a 'Black Box Warning'?

A: The official drug labels for the active ingredient, Hydrotalcite, in major regulatory jurisdictions do not typically carry a 'Black Box Warning.' This is the strongest safety caution that the U.S. Food and Drug Administration (FDA) places on prescription medication labels.


Q: What happens in my body when Ancid starts working?

A: The drug’s action is non-systemic, meaning it is localized entirely to the gastrointestinal tract. It works primarily by directly neutralizing hydrochloric acid in the stomach. Additionally, the change in the local pH environment helps to inhibit the proteolytic activity of the enzyme pepsin.


Q: Is Ancid the same as other medications that treat similar issues?

A: According to official documents, Ancid is classified pharmacologically as a non-systemic antacid. It belongs to the specific group of layered double hydroxides (LDH) and its active ingredient is Hydrotalcite. This classification reflects its unique chemical structure and mechanism compared to some other antacid classes.


Q: How long does it typically take to start feeling the effects of Ancid?

A: Pharmacological studies confirm the rapid onset of acid-neutralizing action, which is a key characteristic of the active ingredient, hydrotalcite. This rapid function is what allows the medicine to provide quick relief from acid-related symptoms.


Q: Do studies show that Ancid is generally well-tolerated?

A: Official information indicates that adverse events reported in early-phase trials were primarily described as mild. The most frequently observed effect in the official Summary of Product Characteristics (SmPC) is soft stools, which is classified as Very Common (occurring in 1 out of 10 or more treated individuals).


Q: Can Ancid cause problems with sleep?

A: The official adverse reactions profile primarily lists gastrointestinal effects and risks related to kidney function. While research studies have measured 'sleep outcomes' in some trials, the primary regulatory texts do not classify specific sleep disturbances as an adverse reaction with a defined frequency.


Q: Is Ancid a steroid?

A: No, Ancid is not a steroid. The active ingredient, Hydrotalcite, is classified pharmacologically as a non-systemic antacid. Chemically, it is described as aluminum magnesium hydroxide carbonate hydrate.


Q: Can Ancid cause dry mouth or changes in taste?

A: Dry mouth was reported as an adverse event in early-phase studies. However, official regulatory documents do not list changes in taste or dry mouth in the frequency-based classification of adverse reactions.


Q: What types of research have been done on Ancid?

A: Research conducted on the compound includes early-phase studies, which focused on the initial pharmacokinetic data (how the body handles the drug) and the side effect profile. This was followed by later Phase III randomized controlled trials (RCTs) that compared the treatment group against a placebo group for specific outcomes.


Q: How does Ancid compare in function to similar, older medications?

A: Ancid is classified as a non-systemic antacid and a layered double hydroxide (LDH), which functions locally as a buffer. The key feature of its non-systemic classification is that its action is localized to the gastrointestinal tract, resulting in minimal absorption into the bloodstream.


Q: Can Ancid cause liver problems?

A: Based on the official frequency-classified adverse reactions in regulatory documents, liver problems are not listed among the main known risks. The safety profile primarily focuses on gastrointestinal effects and risks associated with kidney function and accumulation.


Q: Is Ancid a medication that needs to be taken long-term?

A: Official constraints dictate that Ancid is restricted to short-term symptomatic use for the relief of heartburn and acid indigestion. Long-term, high-dose therapy must be avoided due to the potential for component accumulation in the body.


Q: What does the term 'Ancid' mean or stand for?

A: 'Ancid' is a brand name for a medicine whose active ingredient is Hydrotalcite. The chemical name 'hydrotalcite' is derived from its chemical composition (hydro- for water) and its crystalline structure, which is similar to a mineral called talc.


Q: Is Ancid a controlled substance?

A: No, Ancid is not classified as a controlled substance under major international and US regulatory frameworks. It is an antacid compound used for symptomatic relief of excess gastric acid.


Q: What is the official definition of Ancid's main purpose?

A: The primary therapeutic purpose of Ancid, as officially classified in regulatory documents, is to provide relief from acid indigestion and heartburn. This is achieved by the chemical neutralization of acid within the stomach.


Q: Are there different forms or strengths of Ancid available?

A: Ancid is available in different forms, including chewable tablets and an oral suspension. The dosage forms available include chewable tablets (typically 500 mg) and an oral suspension.


Q: Can Ancid be split or crushed if someone has trouble swallowing pills?

A: Official administration instructions state that solid dosage forms must be thoroughly chewed or crushed before swallowing. This indicates that crushing is an expected part of the administration process for chewable forms.


Q: What are the storage requirements for Ancid?

A: Official product information specifies that Ancid must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must not be frozen and should be kept in its original, tightly closed container.


Q: Are there any major drug classes that should be avoided with Ancid?

A: Yes, regulatory documents highlight that major drug classes susceptible to reduced exposure when taken with Ancid include certain antibiotics (Tetracyclines, Quinolones), Cardiac Glycosides (like Digoxin), Corticosteroids, and Iron Salts. Additionally, co-administration with Sodium Citrate is formally prohibited.


Q: Is it true that Ancid can sometimes worsen a pre-existing condition?

A: Official documents define several conditions that prohibit use (contraindications) or require great caution. These restrictions include severe renal insufficiency and pre-existing hypophosphataemia due to the risk of accumulation of aluminum and magnesium compounds.


Q: Can Ancid be used to prevent certain conditions?

A: Official regulatory documents indicate that Ancid is indicated for the relief of symptoms such as acid indigestion and heartburn. Its official use is restricted to short-term symptomatic use rather than long-term prevention.


Q: Are there any known issues with taking Ancid while breastfeeding?

A: According to official prescribing information, the use of Ancid during lactation is generally permitted. This is based on the assessment that a risk to the newborn is not expected due to the drug's non-systemic action and minimal absorption.

How should Ancid be stored and disposed of?

Ancid must be stored at controlled room temperature, specifically 20ºC to 25ºC (68ºF to 77ºF), and must not be frozen. The product should be kept in its original container and the cap must remain tightly closed to protect it from excessive heat and moisture. Do not use the medicine past the expiry date or if the safety seal is broken.

Disposal

Unused or expired Ancid should not be flushed down the toilet or drain or thrown into household trash. Consult a pharmacist or utilize a governmental drug take-back program for proper disposal. Keep the medication out of the sight and reach of children at all times.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ancid found in:

A-Z Index: